Intravenous Immunoglobulin (IVIg) Market Trend, Segmentation And Industry Analysis Research Report 2017

The Global Intravenous Immunoglobulin (IVIg) Market Research Report provides detailed analysis of the key regional market status of the Intravenous Immunoglobulin (IVIg) Industry.

Global Intravenous Immunoglobulin (IVIg) Market information, by type (IgA, IgD, IgE, IgG, IgM), by Appliaction (Chronic inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia, Multifocal Motor Neuropathy, Immunodeficiency diseases, Primary Humoral Immunodeficiency, Myasthenia Gravis, Guillain-Barre syndrome, Kawasaki disease, ITP, and others) – Forecast to 2023

Market Synopsis of Global Intravenous Immunoglobulin (IVIg) Market:

Global Intravenous Immunoglobulin (IVIg) Market is growing moderately. IVIg is concerned with the treatment of patients who have weak immune system. Human body produces enough antibodies to fight infection causing germs, but if patients is suffering from immune deficiency then body can’t produce enough of them. The increasing demand for alternate immunoglobulin replacement therapies, new innovations, increasing R&D funding, developing healthcare infrastructure and increasing healthcare expenditure are major driving forces of the market. The Global Intravenous Immunoglobulin (IVIg) market is growing at the CAGR of ~5.9% during the forecast period and expected to reach US$ 8337.2 million by 2023.

Segments:   

Global Intravenous Immunoglobulin (IVIg) Market has been segmented on the basis of type which comprise IgA (sub segments- IgA1 and IgA2), IgD, IgE, IgG,. On the basis of application it segmented into CIDP (Progressive, Recurrent, Monophasic), Hypogammaglobulinemia (sub segments- AGM1, AGM2, AGM3, AGM4, AGM5, AGM6), Multifocal Motor Neuropathy, Immunodeficiency diseases (sub segments- X-linked agammaglobulinemia (XLA), common variable immunodeficiency (CVID), severe combined immunodeficiency), Primary Humoral Immunodeficiency (Subsegments- B cell (antibody) deficiencies, T cell deficiencies, Combination B and T cell deficiencies, Defective phagocytes, Complement deficiencies, Unknown (idiopathic)), Myasthenia Gravis (Sub segments- generalized myasthenia gravis, ocular myasthenia gravis, Congenital myasthenia gravis, Transient neonatal myasthenia gravis), Guillain-Barre syndrome (Sub segments- Acute inflammatory demyelinating polyradiculoneuropathy (AIDP), Miller Fisher syndrome (MFS), Acute motor axonal neuropathy (AMAN)and acute motor-sensory axonal neuropathy (AMSAN)), Kawasaki disease, ITP (Sub segments- acute and chronic), and others.

Key Players for Global Intravenous Immunoglobulin (IVIg) Market:         

Some of the key players in this market are: ABEONA THERAPEUTICS (US), Baxter (US), BDI Pharma (US), Biotest AG.(Germany),, China Biologic Products, Inc. (China), CSL Behring (US), Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma (Switzerland), Shire (Republic of Ireland), AND others.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/3137

Regional Analysis of Global Intravenous Immunoglobulin (IVIg) Market:      

Considering the global scenario of the market, North America is believed to be the largest market for Global IVIg. Moreover the European market, especially Western Europe is growing and second largest market for Global IVIg. On the other hand, Asia-Pacific is expected to grow at significant rate in the Global IVIg market during the forecasted period. Middle East and Africa is likely to have a limited but steady growth in the market, particularly market in North Africa is growing as compared to South and East region of Africa due to less awareness of these therapies and treatment.

Study objectives of Global Intravenous Immunoglobulin (IVIg) Market:

To provide detailed analysis of the Global Intravenous Immunoglobulin (IVIg) market structure along with forecast for the next 7 years of the various segments and sub-segments of the IVIG Market

To provide insights about the key drivers and restraints that affecting the growth of the IVIg market

To provide detail analysis of global IVIg market mainly based on Value chain analysis, PROTER’s five forces, Price analysis, and Supply Chain analysis etc.

To provide revenue of the market that includes historical as well as forecast revenue, on the basis of segments and sub segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

To provide detail analysis of the market that segmented on the basis of type, application, and its sub-segments.

To provide detail country level analysis of the market with respect to the current market size and future prospective

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global IVIg Market

To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

Table of Content

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Intravenous Immunoglobulin (IVIg) Market By Type
  7. Global Intravenous Immunoglobulin (IVIg) Market By Application
  8. Global Intravenous Immunoglobulin (IVIg) Market By Region

9          Conclusion

10        Appendix

Enquiry @ https://www.marketresearchfuture.com/enquiry/3137

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

%d bloggers like this: